Floatz logo

PREDNISONE TABLETS

Lymphatic Diseases

UNC Lineberger Comprehensive Cancer CenterSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Lymphatic Diseases cohort.

Asset / SponsorPhaseRating
Zilovertamab
Oncternal Therapeutics, Inc
Phase 3B
Bendamustine
UNC Lineberger Comprehensive Cancer Center
Phase 2B
Zofran
UNC Lineberger Comprehensive Cancer Center
Phase 2B
Ibrutinib
Oncternal Therapeutics, Inc
Phase 3B
Cyclophosphamide
UNC Lineberger Comprehensive Cancer Center
Phase 2B

View all 18 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →